SCHEMBL129876

SCHEMBL129876

Cc1cc2cc3c4cc(-c5ccccc5)c(C)cc4cc[n+]3cc2cc1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.36
MAPT P10636 3/20 0.36
CYP3A4 P08684 1/20 0.36
PSMB5 P28074 1/20 0.35
ESR2 Q92731 1/20 0.34
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
RAB9A P51151 1/20 0.31
RCE1 Q9Y256 1/20 0.31
SQOR Q9Y6N5 1/20 0.31
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
MEN1 O00255 1/20 0.30
HPGD P15428 1/20 0.30
MPI P34949 1/20 0.30
KMT2A Q03164 1/20 0.30
LMNA P02545 1/20 0.30
NR2F2 P24468 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16186792 0.88 RAB9A (0.33) DHFRMAPTCYP3A4ESR2RAB9A
SCHEMBL128772 0.75 CYP3A4 (0.46) MAPTCYP3A4CYP11B1CYP11B2RAB9A
SCHEMBL127933 0.74 CYP3A4 (0.45) MAPTCYP3A4RAB9ARCE1KDM4E
SCHEMBL127939 0.73 CYP3A4 (0.43) MAPTCYP3A4KDM4EALDH1A1MEN1
SCHEMBL129156 0.71 MAPT (0.52) MAPTCYP3A4SQORKDM4EALDH1A1
SCHEMBL25525296 0.68 ALKBH5 (0.32) KDM4E
SCHEMBL13076611 0.68 MAPT (0.51) MAPTCYP3A4RAB9AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL7826957 0.66 CYP3A4 (0.68) MAPTCYP3A4RAB9AKDM4EALDH1A1
SCHEMBL4830408 0.65 ESR2 (0.60) DHFRPSMB5ESR2SQORKDM4E
Ammonia Solution, Strong SCHEMBL27938002 0.64 ESR2 (0.50) DHFRMAPTPSMB5ESR2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227966-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-05 US disclosed
US-20140315939-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-10-23 US disclosed
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L DHFR 987/4885MAPT 4740/4885CYP3A4 464/4885
US-20140315939-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L DHFR 822/4885MAPT 4773/4885CYP3A4 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.